News

ISHLT has issued a new statement, Protecting the Research Enterprise That Advances Thoracic Transplantation and Patient Care, emphasizing the importance of independent peer review, stable and transparent research funding, open scientific communication, scientific meetings, international collaboration, and sustained support for research that advances patient care worldwide. The statement was submitted to the U.S. Office of Management and Budget as part of ISHLT’s public comment on proposed federal funding rules affecting scientific research.

The ISHLT2027 Scientific Program Planning Committee is hosting a webinar on Thursday, 23 July at 12:00 p.m. AEST / Wednesday 22 July at 10:00 p.m. ET on the best practices for submitting an abstract to ISHLT2027.

As ISHLT prepares for another exciting year of innovative research, interested members are invited to apply to serve as Abstract Reviewers for ISHLT2027. Complete the online application by Friday, 31 July at 11:59 p.m. ET / Saturday, 1 August at 03:59 UTC.

In response to a request for public comment from the Organ Procurement and Transplantation Network (OPTN), the International Society for Heart and Lung Transplantation (ISHLT) has submitted official comments on a proposal titled “Update on Lung Continuous Distribution Policy.”

Katelynn Madill-Thomsen and Philip Halloran of the Alberta Transplant Applied Genomics Center guest on the JHLT podcast to discuss how donor-specific antibodies show up in patients with and without AMR in heart transplantation.

Check out this video to learn more about the latest in pulmonary vascular disease topics that were discussed at ISHLT2026 in Toronto this April.

Presented by the ISHLT Early Career and Trainee Committee, this month's ISHLT Journal Watch explores topics in cardiology, mechanical circulatory support, and heart transplantation.

Watch this video to learn more about the latest in mechanical circulatory support (MCS) topics that were discussed at ISHLT2026 in Toronto this April.

In this episode of the ISHLT Voices podcast, hosted by Kamada, you’ll hear experts discuss different cytomegalovirus (CMV) prophylaxis approaches in high-risk lung transplant patients.

Check out this video to learn more about the latest in advanced lung failure and transplantation topics that were discussed at ISHLT2026 in Toronto this April.

A new community on ISHLTconnect is now open to all involved in the management and treatment of advanced heart and lung disease. The ISHLT Pediatric Pulmonology Special Interest Group is open to all with a special interest in pediatric pulmonology.

Watch this video to learn more about the latest in advanced heart failure and transplantation topics that were discussed at ISHLT2026 in Toronto this April.

ISHLT is currently accepting applications from ISHLT members who are interested in serving as Grant Reviewers.

The JHLT will release a special issue in Q4 2026 dedicated to manuscripts exploring aspects of donor selection and organ preservation related to thoracic transplantation. Submissions for this issue are now being accepted until 5:00 p.m. ET on Wednesday, 15 July, 2026.

Heart transplant recipient and patient advocate Payton Herres joins the podcast for a discussion about her recent perspective piece in JHLT on the problems of 'ghost approval' and the difference between health insurance coverage and access to care.

At their industry symposium at ISHLT2026, Natera highlighted how donor-derived cell-free DNA (dd-cfDNA) not only rules out rejection with high confidence, but also detects broader allograft injury. Experts discussed emerging data on EMI, which is strongly linked to poor outcomes, including increased risk of CLAD.

The ISHLT Strategic Investment Fund is now accepting proposals from ISHLT members. The Fund is designed to identify and launch ISHLT-led initiatives that advance the field of advanced heart and lung disease therapies, deliver meaningful value to members worldwide, and strengthen the Society’s leadership, programs, and long-term impact. Proposals are due by Tuesday, 18 August.

A new ISHLT Document, ISHLT Scientific Statement on Pulmonary Antibody-Mediated Rejection and Proposed Graft, Antibody, and Pathology (GAP) Definition, has been published in JHLT and is available to read online!

With the U.S. OPTN public comment period for the newly implemented Lung Composite Allocation Score (CAS) policy open through July 3, the ISHLT Advanced Lung Failure and Transplant (ALFTX) Interdisciplinary Network is convening an expert webinar to help the transplant community understand what's changing, and what's at stake.

The ISHLT and the Heart Failure Society of America (HFSA) have launched a free, five-part on-demand seminar series designed specifically for nursing and allied health professionals in advanced heart and lung transplant care. Available now.